Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: IsoRay Medical, Inc. (0) Acquired (3)
[203pb]vmt01 (2 trials)
[212pb]vmt-α-net, (1 trial)
pembrolizumab (keytruda) (1 trial)
Key: IsoRay Medical, Inc. (0) Acquired (2)
[203pb]vmt-α-net (1 trial)
[68ga]vmt02 (1 trial)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Trials (5 total)
Trial APIs (5 total)